ES2143487T3 - 1,2,4-oxadiazolil-fenoxialquilisoxazoles y su empleo como agentes antivirales. - Google Patents

1,2,4-oxadiazolil-fenoxialquilisoxazoles y su empleo como agentes antivirales.

Info

Publication number
ES2143487T3
ES2143487T3 ES93201058T ES93201058T ES2143487T3 ES 2143487 T3 ES2143487 T3 ES 2143487T3 ES 93201058 T ES93201058 T ES 93201058T ES 93201058 T ES93201058 T ES 93201058T ES 2143487 T3 ES2143487 T3 ES 2143487T3
Authority
ES
Spain
Prior art keywords
antiviral agents
alcoxy
alkylene
atoms
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93201058T
Other languages
English (en)
Spanish (es)
Inventor
Guy Dominic Diana
Theodore John Nitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Application granted granted Critical
Publication of ES2143487T3 publication Critical patent/ES2143487T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES93201058T 1992-04-15 1993-04-13 1,2,4-oxadiazolil-fenoxialquilisoxazoles y su empleo como agentes antivirales. Expired - Lifetime ES2143487T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/869,287 US5349068A (en) 1992-04-15 1992-04-15 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents

Publications (1)

Publication Number Publication Date
ES2143487T3 true ES2143487T3 (es) 2000-05-16

Family

ID=25353269

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93201058T Expired - Lifetime ES2143487T3 (es) 1992-04-15 1993-04-13 1,2,4-oxadiazolil-fenoxialquilisoxazoles y su empleo como agentes antivirales.

Country Status (26)

Country Link
US (3) US5349068A (en:Method)
EP (1) EP0566199B1 (en:Method)
JP (1) JP3103845B2 (en:Method)
KR (1) KR100314158B1 (en:Method)
AT (1) ATE189958T1 (en:Method)
AU (1) AU666528B2 (en:Method)
CA (1) CA2094012C (en:Method)
CZ (1) CZ285845B6 (en:Method)
DE (1) DE69327913T2 (en:Method)
DK (1) DK0566199T3 (en:Method)
ES (1) ES2143487T3 (en:Method)
FI (1) FI112229B (en:Method)
GR (1) GR3033486T3 (en:Method)
HU (2) HU220606B1 (en:Method)
IL (1) IL105372A (en:Method)
MX (1) MX9302169A (en:Method)
MY (1) MY110191A (en:Method)
NO (1) NO302700B1 (en:Method)
NZ (1) NZ247411A (en:Method)
PH (1) PH30454A (en:Method)
PT (1) PT566199E (en:Method)
RU (1) RU2114112C1 (en:Method)
SG (1) SG50663A1 (en:Method)
SK (1) SK279786B6 (en:Method)
TW (1) TW239140B (en:Method)
UA (1) UA35557C2 (en:Method)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5349068A (en) * 1992-04-15 1994-09-20 Sterling Winthrop Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US5552420A (en) * 1994-05-13 1996-09-03 Sterling Winthrop Inc. Therapeutic phenoxyalkylazoles and phenoxyalkylazines
IL118657A0 (en) * 1996-06-14 1996-10-16 Arad Dorit Inhibitors for picornavirus proteases
IL122591A0 (en) 1997-12-14 1998-06-15 Arad Dorit Pharmaceutical compositions comprising cystein protease inhibitors
US6348324B1 (en) 1999-01-21 2002-02-19 Hypoguard America Limited Composition and device for detecting leukocytes in urine
US6528652B1 (en) * 1999-01-21 2003-03-04 Chronimed Composition and device for detecting leukocytes in urine
AUPQ105499A0 (en) 1999-06-18 1999-07-08 Biota Scientific Management Pty Ltd Antiviral agents
AUPR213700A0 (en) * 2000-12-18 2001-01-25 Biota Scientific Management Pty Ltd Antiviral agents
MXPA03011196A (es) * 2001-06-08 2004-10-28 Cytovia Inc 3-aril-5-aril-[1,2,4]-oxadiazoles sustituidos y analogos.
US7129359B2 (en) * 2002-07-09 2006-10-31 National Health Research Institutes Imidazolidinone compounds
CA2459376A1 (en) * 2001-08-29 2003-03-13 Viropharma Incorporated Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents
WO2003020270A1 (en) * 2001-08-29 2003-03-13 Viropharma Incorporated Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents
US7652050B2 (en) 2001-12-07 2010-01-26 Laboratorio de Siagnóstico GAM S.A Methods for increasing the survival of aquatic animals infected with an aquatic virus
US20060167109A1 (en) * 2002-02-14 2006-07-27 Pevear Daniel C Methods of reducing rhinovirus contagion and related compositions
EP1581213A4 (en) * 2002-12-18 2008-11-19 Cytovia Inc 3,5-DISUBSTITUTED 1,2,4-OXADIAZOLE AND ANALOGUE TO ACTIVATE CASPASE AND INTRODUCTION OF APOPTOSIS AND THEIR USE
US7259174B2 (en) * 2004-05-25 2007-08-21 National Health Research Institutes Imidazolidinone compounds
CA2575932A1 (en) * 2004-08-04 2006-02-16 Schering Corporation Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
WO2007095043A2 (en) * 2006-02-09 2007-08-23 Schering Corporation Pharmaceutical formulations
AR059357A1 (es) * 2006-02-09 2008-03-26 Schering Corp Formulaciones farmaceuticas
WO2007095041A2 (en) * 2006-02-09 2007-08-23 Schering Corporation Pharmaceutical formulations
CN101553483B (zh) 2006-12-13 2013-04-17 弗·哈夫曼-拉罗切有限公司 作为非核苷逆转录酶抑制剂的2-(哌啶-4-基)-4-苯氧基-或苯基氨基-嘧啶衍生物
KR101031584B1 (ko) * 2009-04-21 2011-04-27 파인오토시스템(주) 전면부가 개폐되는 차량용 적외선 조사장치
CN103102322B (zh) * 2011-11-14 2016-02-24 上海交通大学 噁唑类化合物及其制备方法、药物组合物及其用途
CN112752761B (zh) 2018-08-21 2024-03-29 杏林制药株式会社 双环杂芳族环衍生物
CA3152534A1 (en) * 2019-09-27 2021-04-01 Collaborations Pharmaceuticals, Inc. Isoxazole-3-carboxamide derivatives and their use for treatment of diseases caused by virus infection
WO2021209563A1 (en) 2020-04-16 2021-10-21 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861791A (en) * 1983-08-29 1989-08-29 Sterling Drug Inc. Dihydro-oxazolyl substituted-phenyl-aliphatic lower alkyl and their use as antiviral agents
ZA846525B (en) * 1983-08-29 1985-04-24 Sterling Drug Inc (substituted)phenyl-aliphatic-isoxazoles useful as antiviral agents and preparation thereof
US4843087A (en) * 1983-08-29 1989-06-27 Sterling Drug Inc. Di-heterocyclic compounds and their use as antiviral agents
CA1280753C (en) * 1985-07-02 1991-02-26 Philip Michael Carabateas Process for preparing heterocyclic substituted- phenoxyalkyl isoxazoles and-furans
GB8619433D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
US5175178A (en) * 1989-08-21 1992-12-29 Sterling Drug Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
NZ234760A (en) * 1989-08-18 1991-09-25 Sterling Drug Inc Antiviral oxazole compounds and compositions
US4942241A (en) * 1989-08-21 1990-07-17 Sterling Drug Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US4945164A (en) * 1989-08-18 1990-07-31 Sterling Drug Inc. 1,3,4-Oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents and intermediates thereof
US5175177A (en) * 1991-07-17 1992-12-29 Sterling Drug Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US5349068A (en) * 1992-04-15 1994-09-20 Sterling Winthrop Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents

Also Published As

Publication number Publication date
FI931707L (fi) 1993-10-16
HU220606B1 (hu) 2002-03-28
HU211320A9 (en) 1995-11-28
PT566199E (pt) 2000-09-29
JP3103845B2 (ja) 2000-10-30
IL105372A0 (en) 1993-08-18
FI112229B (fi) 2003-11-14
US5643929A (en) 1997-07-01
AU3688193A (en) 1993-10-21
EP0566199B1 (en) 2000-03-01
RU2114112C1 (ru) 1998-06-27
AU666528B2 (en) 1996-02-15
CZ59793A3 (en) 1994-02-16
HUT65574A (en) 1994-07-28
JPH0649066A (ja) 1994-02-22
KR100314158B1 (ko) 2002-02-19
US5464848A (en) 1995-11-07
SK35393A3 (en) 1994-06-08
HU9301084D0 (en) 1993-06-28
ATE189958T1 (de) 2000-03-15
SG50663A1 (en) 1998-07-20
CA2094012A1 (en) 1993-10-16
UA35557C2 (uk) 2001-04-16
US5349068A (en) 1994-09-20
FI931707A0 (fi) 1993-04-15
GR3033486T3 (en) 2000-09-29
NO302700B1 (no) 1998-04-14
EP0566199A1 (en) 1993-10-20
KR930021637A (ko) 1993-11-22
DE69327913D1 (de) 2000-04-06
MX9302169A (es) 1993-10-01
CZ285845B6 (cs) 1999-11-17
DE69327913T2 (de) 2000-10-12
PH30454A (en) 1997-05-28
IL105372A (en) 1998-12-27
NO931366L (no) 1993-10-18
SK279786B6 (sk) 1999-03-12
NO931366D0 (no) 1993-04-14
MY110191A (en) 1998-02-28
TW239140B (en:Method) 1995-01-21
DK0566199T3 (da) 2000-06-19
CA2094012C (en) 2001-08-21
NZ247411A (en) 1994-06-27

Similar Documents

Publication Publication Date Title
ES2143487T3 (es) 1,2,4-oxadiazolil-fenoxialquilisoxazoles y su empleo como agentes antivirales.
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
ES2194314T3 (es) Derivados de benzopirano sustituidos para el tratamiento de inflamaciones.
CO4440628A1 (es) Derivados de pirimidina condensados con un anillo heteroci- clico
ES2080739T3 (es) Nitro-compuestos insecticidamente activos.
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
KR0141913B1 (en) Anti-virus agents
GB9408185D0 (en) New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
ES2108717T3 (es) Derivados de la tetrahidropirrolo(1,2-a)pirazina-4-espiro-3'-pirrolidina, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
ES2160602T3 (es) Derivados de quinolona y acridinona para el tratamiento de la incontinencia urinaria.
ES2118203T3 (es) Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2123873T3 (es) Pirrolocarbazol.
ES2107035T3 (es) Derivados de 3-azabiciclo(3.2.0)heptano n-substituidos como neurolepticos etc..
ES2189941T3 (es) Derivados de nucleosidos aciclicos.
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
MX9303990A (es) Tetrazolil (fenoxi y fenoxialquil) piperidinil piridazinas como agentes antivirales.
ES2125963T3 (es) Nuevos derivados espiranicos del 3-amino-cromano, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
DK624989D0 (da) Hidtil ukendte forbindelser
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.
MX9204194A (es) Los compuestos de 1,2,4-oxadiazolil-fenoxialquilisoxazolas y su uso como agentes antivirales
ES2059550T3 (es) Derivados de la bencimidazola, su preparacion y su aplicacion en terapeutica.
DE3666223D1 (en) Anticonvulsant agents
ES2117003T3 (es) Derivados oligopeptidicos de hipoxantina dotados de actividad inmunomoduladora, y composiciones farmaceuticas que los contienen.
ES2138052T3 (es) Derivados de ciclopropano y agentes antiviricos que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 566199

Country of ref document: ES